Clovis Oncology, Inc. Recorded Big Gain
Tue, Jun 21, 2022 at 08:21 PM
Clovis Oncology, Inc. (CLVS:NASDAQ) soared at $1.64, a gain of 39%. On Tue, Jun 21, 2022, CLVS:NASDAQ touched a New 2-Week High of $1.64. The stock got featured on our News Catalysts scanner on Thu, Jun 16, 2022 at 07:32 PM in the 'BIOTECH' category. From Tue, Jun 07, 2022, the stock recorded 66.67% Up Days and 60.00% Green Days
The stock spiked on Tue, Jun 21, 2022 at $2.4 with a volume of 109M+.
About Clovis Oncology, Inc. (CLVS:NASDAQ)
Clovis Oncology Inc is a biopharmaceutical company focused on acquiring, developing and commercializing cancer treatments in the United States, Europe and other international markets.
Top 10 Gainers:
- RISE Education Cayman Ltd (REDU:NASDAQ), 138.46%
- Convey Health Solutions Holdings Inc. (CNVY:NYSE), 138.43%
- Valneva SE (VALN:NASDAQ), 93.14%
- Revlon, Inc. (REV:NYSE), 62.47%
- Great Panther Mining Limited (GPL:NYSEMKT), 51.8%
- G Medical Innovations Holdings Ltd. (GMVD:NASDAQ), 45.45%
- Clovis Oncology, Inc. (CLVS:NASDAQ), 38.98%
- CEA Industries Inc. (CEAD:NASDAQ), 38.24%
- Greenbox POS (GBOX:NASDAQ), 36.36%
- Innate Pharma S.A. (IPHA:NASDAQ), 34%